TAM
COCHW icon

Terrapin Asset Management’s Envoy Medical Warrant COCHW Stock Holding History

Terrapin Asset Management’s Portfolio COCHW Stock Details COCHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,666
Closed -$253 – 105
2022
Q4 		$253 Buy
+6,666
New +$316 ﹤0.01% 236

Other funds holding COCHW

BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Terrapin Asset Management's COCHW Position: Q1 2023 in Review

Terrapin Asset Management sold out of Envoy Medical Warrant (COCHW) in Q1 2023, closing a stake of 6,666 shares — an estimated $253 sold.

Terrapin Asset Management first reported a position in COCHW in Q4 2022 and held it in 1 quarter. The position peaked at $253 in Q4 2022. 62 funds tracked by Wall St. Rank hold COCHW as of Q1 2023.

  • Terrapin Asset Management reported no remaining Envoy Medical Warrant position as of Q1 2023 after selling out during the quarter.
  • Terrapin Asset Management sold 6,666 Envoy Medical Warrant shares in Q1 2023, an estimated $253.
  • Terrapin Asset Management first reported a position in Envoy Medical Warrant in Q4 2022 and held it in 1 quarter.
  • Terrapin Asset Management's Envoy Medical Warrant position peaked at $253 in Q4 2022.
  • 62 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2023.

Based on Terrapin Asset Management's 13F filing for Q1 2023, filed 12 May 2023.